First AD

Second AD

Early Detection of CKD in Stages 2 and 3

How can early detection of CKD in stages 2 and 3 improve patient outcomes across your individual specialties (eg, nephrology, cardiology, primary care)?

Enhancing CKD Care in Type 2 Diabetes: Bridging Gaps in Diagnosis, Treatment, and Patient Outcomes

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Early detection of chronic kidney disease (CKD) in stages 2 and 3 can significantly enhance patient outcomes by enabling timely intervention and management. In nephrology, early identification allows for the implementation of strategies to slow disease progression and preserve renal function. Cardiology benefits from early detection by addressing cardiovascular risk factors associated with CKD, reducing the incidence of cardiovascular events. Primary care providers can coordinate comprehensive care plans, ensuring patients receive appropriate referrals and lifestyle modifications. Overall, early detection facilitates a multidisciplinary approach, improving quality of life and reducing healthcare costs.

Panelists discuss how early detection of chronic kidney disease (CKD) in stages 2 and 3 can improve patient outcomes across various specialties, including nephrology, cardiology, and primary care.